MREO
Price
$2.47
Change
-$0.18 (-6.79%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
391.94M
124 days until earnings call
RXRX
Price
$4.56
Change
-$0.35 (-7.13%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
1.85B
68 days until earnings call
Interact to see
Advertisement

MREO vs RXRX

Header iconMREO vs RXRX Comparison
Open Charts MREO vs RXRXBanner chart's image
Mereo BioPharma Group
Price$2.47
Change-$0.18 (-6.79%)
Volume$9.83K
Capitalization391.94M
Recursion Pharmaceuticals
Price$4.56
Change-$0.35 (-7.13%)
Volume$127.39K
Capitalization1.85B
MREO vs RXRX Comparison Chart
Loading...
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MREO vs. RXRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (MREO: $2.55 vs. RXRX: $4.91)
Brand notoriety: MREO and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 189% vs. RXRX: 209%
Market capitalization -- MREO: $391.94M vs. RXRX: $2B
MREO [@Biotechnology] is valued at $391.94M. RXRX’s [@Biotechnology] market capitalization is $2B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MREO is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • MREO’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than MREO.

Price Growth

MREO (@Biotechnology) experienced а +16.44% price change this week, while RXRX (@Biotechnology) price change was +11.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

MREO is expected to report earnings on Oct 07, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.85B) has a higher market cap than MREO($392M). MREO (-27.143) and RXRX (-27.367) have similar YTD gains . MREO has higher annual earnings (EBITDA): -43.41M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. MREO (80.5M). MREO has less debt than RXRX: MREO (6.68M) vs RXRX (92.9M). RXRX has higher revenues than MREO: RXRX (59.8M) vs MREO (1M).
MREORXRXMREO / RXRX
Capitalization392M1.85B21%
EBITDA-43.41M-524.77M8%
Gain YTD-27.143-27.36799%
P/E RatioN/AN/A-
Revenue1M59.8M2%
Total Cash80.5M500M16%
Total Debt6.68M92.9M7%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MREORXRX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 22 days ago
88%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGIX72.270.15
+0.21%
Janus Henderson Growth And Income D
PDECX16.20N/A
N/A
PGIM Jennison Emerging Markets Eq Opps C
TDFCX8.15N/A
N/A
Transamerica Sustainable Equity Inc C
CMGVX29.42N/A
N/A
Columbia Select Mid Cap Gro Fd I2
GEBSX10.71N/A
N/A
Goldman Sachs ESG Em Mkts Eq R6

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+11.85%
CRSP - RXRX
72%
Closely correlated
+0.03%
BEAM - RXRX
63%
Loosely correlated
+1.60%
ABSI - RXRX
60%
Loosely correlated
+2.52%
ABCL - RXRX
60%
Loosely correlated
+4.76%
NTLA - RXRX
57%
Loosely correlated
-0.26%
More